Observations placeholder
Azathioprine and Imuran
Identifier
017706
Type of Spiritual Experience
Background
A description of the experience
Azathioprine is an immunosuppressive drug used in organ transplantation and autoimmune diseases and belongs to the chemical class of purine analogues. Synthesized originally as a cancer drug and a prodrug for mercaptopurine in 1957, it has been widely used as an immunosuppressant for more than 50 years.
The main adverse effect of azathioprine is bone marrow suppression, which can be life-threatening. It is also listed by the International Agency for Research on Cancer as a group 1 carcinogen (carcinogenic to humans).
Azathioprine is produced by a number of manufacturers under different brand names Azasan in the U.S., Imuran in Canada, the U.S., Australia, Ireland and the United Kingdom, Azamun in Finland, and Imurel in Scandinavia and France, among others. It is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system.
On Sep, 10, 2015: 14,262 people reported to have side effects when taking Azathioprine. Among them, 22 people (0.15%) have Hallucination.
On Jan, 11, 2017 15,164 people reported to have side effects when taking Imuran. Among them, 23 people (0.15%) have Hallucination
when sold under the brand name Imuran, Azathioprine (AZA), is used in rheumatoid arthritis, Crohn's disease, ulcerative colitis, and in kidney transplants to prevent rejection.[sic] It is taken by mouth or injected into a vein.
On Oct, 23, 2017 16,335 people reported to have side effects when taking Imuran.
Among them, 191 people (1.17%) have Death
The source of the experience
eHealthmeConcepts, symbols and science items
Concepts
Symbols
Science Items
Purine synthesis inhibitorsActivities and commonsteps
Activities
Overloads
Autoimmune diseasesCrohns disease
Immunosuppressants
Multiple sclerosis treatments
Myasthenia gravis
Rheumatoid arthritis
Skin diseases
Suppressions
Multiple sclerosisOrgan transplantation